CBD Co. Inks $712K Deal To End Investors' Securities Suit
Investors who accused CBD company CV Sciences Inc. of misleading them about a rejected patent application have reached a tentative $712,500 settlement with the business to end their claims, Nevada federal court...To view the full article, register now.
Already a subscriber? Click here to view full article